A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children ’s Oncology Group Phase 1 and Pilot Consortium Trial (ADVL1315)
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 5, 2018 Category: Cancer & Oncology Authors: James I. Geller,
Elizabeth Fox,
Brian K. Turpin,
Stuart L. Goldstein,
Xiaowei Liu,
Charles G. Minard,
Rachel A. Kudgus,
Joel M. Reid,
Stacey L. Berg,
Brenda J. Weigel Source Type: research
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Ajai Chari,
Sagar Lonial,
Tomer M. Mark,
Amrita Y. Krishnan,
Keith E. Stockerl ‐Goldstein,
Saad Z. Usmani,
Anil Londhe,
Delores Etheredge,
Sarah Fleming,
Baolian Liu,
Jon Ukropec,
Thomas S. Lin,
Sundar Jagannath,
Ajay K. Nooka Source Type: research
Risk of incident claims for chemotherapy ‐induced peripheral neuropathy among women with breast cancer in a Medicare population
CONCLUSIONSThese Medicare claims database findings indicate that women aged 66 years or older with breast cancer are susceptible to CIPN from taxane and/or platinum compounds, with risk emerging approximately 3 months into treatment. Prospective studies of symptom emergence and clinical response (eg, stopping chemotherapy and adjunctive treatments) are indicated to determine how best to inform patients of this risk and to manage CIPN in this population. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Mark K. Greenwald,
Julie J. Ruterbusch,
Jennifer L. Beebe ‐Dimmer,
Michael S. Simon,
Terrance L. Albrecht,
Ann G. Schwartz Tags: Original Article Source Type: research
Food and Drug Administration ’s regulatory shift on direct‐to‐consumer genetic tests for cancer risk
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Y. Tony Yang,
Patricia J. Zettler Tags: Commentary Source Type: research
Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy?
ConclusionsThe benefit of chemotherapy for patients with breast cancer who have an intermediate RS is driven in a nonlinear fashion by RS: the higher the RS, the larger the absolute benefit. Findings from this study underscore the utility of real ‐world data to inform joint decision making in practice. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Abiola F. Ibraheem,
David J. Press,
Olufunmilayo I. Olopade,
Dezheng Huo Tags: Original Article Source Type: research
Lymph node involvement: Positive about the role of the recurrence score in estrogen ‐driven breast cancer?
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Kevin Kalinsky,
Ruth M. O ’Regan Tags: Editorial Source Type: research
Issue Information
Cancer,Volume 124, Issue 18, Page 3623-3630, September 15, 2018. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Source Type: research
Survivors of endometrial cancer are more likely to experience cardiovascular problems
Cancer,Volume 124, Issue 18, Page 3633-3633, September 15, 2018. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Source Type: research
Study finds that cash is effective, but e ‐cigarettes are not in helping smokers quit
Cancer,Volume 124, Issue 18, Page 3632-3633, September 15, 2018. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Source Type: research
American Cancer Society updates its colorectal cancer screening guideline
Cancer,Volume 124, Issue 18, Page 3631-3632, September 15, 2018. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Source Type: research
Risk of incident claims for chemotherapy ‐induced peripheral neuropathy among women with breast cancer in a Medicare population
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Mark K. Greenwald,
Julie J. Ruterbusch,
Jennifer L. Beebe ‐Dimmer,
Michael S. Simon,
Terrance L. Albrecht,
Ann G. Schwartz Source Type: research
Food and Drug Administration ’s regulatory shift on direct‐to‐consumer genetic tests for cancer risk
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Y. Tony Yang,
Patricia J. Zettler Source Type: research
Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy?
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Abiola F. Ibraheem,
David J. Press,
Olufunmilayo I. Olopade,
Dezheng Huo Source Type: research
Lymph node involvement: Positive about the role of the recurrence score in estrogen ‐driven breast cancer?
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Kevin Kalinsky,
Ruth M. O ’Regan Source Type: research
